These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25935642)

  • 21. The design and discovery of novel amide CCR5 antagonists.
    Pryde DC; Corless M; Fenwick DR; Mason HJ; Stammen BC; Stephenson PT; Ellis D; Bachelor D; Gordon D; Barber CG; Wood A; Middleton DS; Blakemore DC; Parsons GC; Eastwood R; Platts MY; Statham K; Paradowski KA; Burt C; Klute W
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1084-8. PubMed ID: 19167884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differentiation of ROMK potency from hERG potency in the phenacetyl piperazine series through heterocycle incorporation.
    Walsh SP; Shahripour A; Tang H; de Jesus RK; Teumelsan N; Zhu Y; Frie J; Priest BT; Swensen AM; Alonso-Galicia M; Felix JP; Brochu RM; Bailey T; Thomas-Fowlkes B; Zhou X; Pai LY; Hampton C; Hernandez M; Owens K; Ehrhart J; Roy S; Kaczorowski GJ; Yang L; Garcia ML; Pasternak A
    Bioorg Med Chem Lett; 2016 May; 26(9):2339-43. PubMed ID: 27017115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel 4,4-disubstituted piperidine-based C-C chemokine receptor-5 inhibitors with high potency against human immunodeficiency virus-1 and an improved human ether-a-go-go related gene (hERG) profile.
    Kazmierski WM; Anderson DL; Aquino C; Chauder BA; Duan M; Ferris R; Kenakin T; Koble CS; Lang DG; McIntyre MS; Peckham J; Watson C; Wheelan P; Spaltenstein A; Wire MB; Svolto A; Youngman M
    J Med Chem; 2011 Jun; 54(11):3756-67. PubMed ID: 21539377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of novel pyrimidine and malonamide derivatives as TGR5 agonists.
    Park EJ; Ahn YG; Jung SH; Bang HJ; Kim M; Hong DJ; Kim J; Suh KH; Kim YJ; Kim D; Kim EY; Lee K; Min KH
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4271-5. PubMed ID: 25082126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and SAR of novel CXCR4 antagonists that are potent inhibitors of T tropic (X4) HIV-1 replication.
    Skerlj R; Bridger G; McEachern E; Harwig C; Smith C; Wilson T; Veale D; Yee H; Crawford J; Skupinska K; Wauthy R; Yang W; Zhu Y; Bogucki D; Di Fluri M; Langille J; Huskens D; De Clercq E; Schols D
    Bioorg Med Chem Lett; 2011 Jan; 21(1):262-6. PubMed ID: 21109432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclic zinc-dithiocarbamate-S,S'-dioxide blocks CXCR4-mediated HIV-1 infection.
    Takamune N; Misumi S; Shoji S
    Biochem Biophys Res Commun; 2000 Jun; 272(2):351-6. PubMed ID: 10833417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of evocalcet, a next-generation calcium-sensing receptor agonist for the treatment of hyperparathyroidism.
    Miyazaki H; Ikeda Y; Sakurai O; Miyake T; Tsubota R; Okabe J; Kuroda M; Hisada Y; Yanagida T; Yoneda H; Tsukumo Y; Tokunaga S; Kawata T; Ohashi R; Fukuda H; Kojima K; Kannami A; Kifuji T; Sato N; Idei A; Iguchi T; Sakairi T; Moritani Y
    Bioorg Med Chem Lett; 2018 Jun; 28(11):2055-2060. PubMed ID: 29724589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of fluoroquinolones on HERG channels and on pancreatic beta-cell ATP-sensitive K+ channels.
    Zünkler BJ; Claassen S; Wos-Maganga M; Rustenbeck I; Holzgrabe U
    Toxicology; 2006 Dec; 228(2-3):239-48. PubMed ID: 17027138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery and pharmacological profile of new hydrophilic 5-HT(4) receptor antagonists.
    Brudeli B; Navaratnarajah M; Andressen KW; Manfra O; Moltzau LR; Nilsen NO; Levy FO; Klaveness J
    Bioorg Med Chem Lett; 2014 Sep; 24(18):4598-4602. PubMed ID: 25149506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of
    Tahirovic YA; Truax VM; Wilson RJ; Jecs E; Nguyen HH; Miller EJ; Kim MB; Kuo KM; Wang T; Sum CS; Cvijic ME; Schroeder GM; Wilson LJ; Liotta DC
    ACS Med Chem Lett; 2018 May; 9(5):446-451. PubMed ID: 29795757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV chemokine receptor inhibitors as novel anti-HIV drugs.
    Princen K; Schols D
    Cytokine Growth Factor Rev; 2005 Dec; 16(6):659-77. PubMed ID: 16005254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel N-substituted benzimidazole CXCR4 antagonists as potential anti-HIV agents.
    Miller JF; Turner EM; Gudmundsson KS; Jenkinson S; Spaltenstein A; Thomson M; Wheelan P
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2125-8. PubMed ID: 20207537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paradoxical downregulation of CXC chemokine receptor 4 induced by polyphemusin II-derived antagonists.
    Masuda R; Oishi S; Tanahara N; Ohno H; Hirasawa A; Tsujimoto G; Yano Y; Matsuzaki K; Navenot JM; Peiper SC; Fujii N
    Bioconjug Chem; 2012 Jun; 23(6):1259-65. PubMed ID: 22486464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1H-Pyrazolo[3,4-g]hexahydro-isoquinolines as potent GR antagonists with reduced hERG inhibition and an improved pharmacokinetic profile.
    Hunt HJ; Belanoff JK; Golding E; Gourdet B; Phillips T; Swift D; Thomas J; Unitt JF; Walters I
    Bioorg Med Chem Lett; 2015 Dec; 25(24):5720-5. PubMed ID: 26546213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Piperazine-based CCR5 antagonists as HIV-1 inhibitors. IV. Discovery of 1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]- 4-[4-[2-methoxy-1(R)-4-(trifluoromethyl)phenyl]ethyl-3(S)-methyl-1-piperazinyl]- 4-methylpiperidine (Sch-417690/Sch-D), a potent, highly selective, and orally bioavailable CCR5 antagonist.
    Tagat JR; McCombie SW; Nazareno D; Labroli MA; Xiao Y; Steensma RW; Strizki JM; Baroudy BM; Cox K; Lachowicz J; Varty G; Watkins R
    J Med Chem; 2004 May; 47(10):2405-8. PubMed ID: 15115380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, Synthesis, and Pharmacological Evaluation of Second-Generation Tetrahydroisoquinoline-Based CXCR4 Antagonists with Favorable ADME Properties.
    Nguyen HH; Kim MB; Wilson RJ; Butch CJ; Kuo KM; Miller EJ; Tahirovic YA; Jecs E; Truax VM; Wang T; Sum CS; Cvijic ME; Schroeder GM; Wilson LJ; Liotta DC
    J Med Chem; 2018 Aug; 61(16):7168-7188. PubMed ID: 30052039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and SAR of novel isoquinoline CXCR4 antagonists with potent anti-HIV activity.
    Miller JF; Gudmundsson KS; D'Aurora Richardson L; Jenkinson S; Spaltenstein A; Thomson M; Wheelan P
    Bioorg Med Chem Lett; 2010 May; 20(10):3026-30. PubMed ID: 20443225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aminomethyl tetrahydronaphthalene ketopiperazine MCH-R1 antagonists--Increasing selectivity over hERG.
    Meyers KM; Méndez-Andino JL; Colson AO; Warshakoon NC; Wos JA; Mitchell MC; Hodge KM; Howard JM; Ackley DC; Holbert JK; Mittelstadt SW; Dowty ME; Obringer CM; Reizes O; Hu XE
    Bioorg Med Chem Lett; 2007 Feb; 17(3):819-22. PubMed ID: 17107796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacophore modeling for antitargets.
    Thai KM; Ngo TD; Tran TD; Le MT
    Curr Top Med Chem; 2013; 13(9):1002-14. PubMed ID: 23651480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The discovery of fused oxadiazepines as gamma secretase modulators for treatment of Alzheimer's disease.
    Li H; Qin J; Dhondi P; Zhou W; Vicarel M; Bara T; Cole D; Josien H; Pissarnitski D; Zhu Z; Palani A; Aslanian R; Clader J; Czarniecki M; Greenlee W; Cohen-Williams M; Hyde L; Song L; Zhang L; Chu I; Huang X
    Bioorg Med Chem Lett; 2013 Jan; 23(2):466-71. PubMed ID: 23253441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.